Anton Pohanka

1.5k total citations
51 papers, 1.2k citations indexed

About

Anton Pohanka is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anton Pohanka has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anton Pohanka's work include Atrial Fibrillation Management and Outcomes (11 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Cardiac Arrhythmias and Treatments (9 papers). Anton Pohanka is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Cardiac Arrhythmias and Treatments (9 papers). Anton Pohanka collaborates with scholars based in Sweden, United States and Uganda. Anton Pohanka's co-authors include Olof Beck, Jovan P. Antović, Rickard E. Malmström, Rana Said, Lars L. Gustafsson, Yuko Rönquist-Nii, Anders Broberg, Mohamed Abdel‐Rehim, Jolanta J. Levenfors and Mika Skeppholm and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Anton Pohanka

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Pohanka Sweden 23 367 210 193 165 153 51 1.2k
Shitalben Patel United States 22 170 0.5× 24 0.1× 207 1.1× 111 0.7× 126 0.8× 66 1.5k
X.-J. Zhao United States 11 150 0.4× 29 0.1× 160 0.8× 23 0.1× 89 0.6× 16 1.0k
Mark A. Gill United States 17 52 0.1× 19 0.1× 422 2.2× 89 0.5× 78 0.5× 60 987
Therese M Chapman United Kingdom 14 103 0.3× 25 0.1× 88 0.5× 34 0.2× 26 0.2× 17 830
Heather A. Friedel 10 102 0.3× 17 0.1× 149 0.8× 22 0.1× 50 0.3× 11 797
HJ Rogers United Kingdom 21 55 0.1× 35 0.2× 197 1.0× 18 0.1× 80 0.5× 38 948
B. Diquet France 18 66 0.2× 6 0.0× 210 1.1× 37 0.2× 93 0.6× 62 1.2k
Charles M. Bliss United States 8 36 0.1× 21 0.1× 49 0.3× 70 0.4× 41 0.3× 14 1.0k
Nancy K. Hopkins United States 19 77 0.2× 9 0.0× 485 2.5× 69 0.4× 49 0.3× 24 1.1k
Francesca Esposito Italy 29 182 0.5× 23 0.1× 102 0.5× 98 0.6× 41 0.3× 94 2.2k

Countries citing papers authored by Anton Pohanka

Since Specialization
Citations

This map shows the geographic impact of Anton Pohanka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Pohanka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Pohanka more than expected).

Fields of papers citing papers by Anton Pohanka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Pohanka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Pohanka. The network helps show where Anton Pohanka may publish in the future.

Co-authorship network of co-authors of Anton Pohanka

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Pohanka. A scholar is included among the top collaborators of Anton Pohanka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Pohanka. Anton Pohanka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pohanka, Anton, et al.. (2023). Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport. Drug Testing and Analysis. 16(8). 827–834. 6 indexed citations
3.
Pohanka, Anton, et al.. (2023). Detection of anabolic androgenic steroids in serum samples. Drug Testing and Analysis. 15(6). 678–688. 5 indexed citations
4.
Lehtihet, Mikael, et al.. (2022). Studies of IGF-I and Klotho Protein in Relation to Anabolic-Androgenic Steroid and Growth Hormone Administrations. Frontiers in Sports and Active Living. 4. 829940–829940. 2 indexed citations
5.
Blennow, Mats, et al.. (2021). Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low. European Journal of Clinical Pharmacology. 77(9). 1323–1331. 20 indexed citations
6.
Mavri, Alenka, Nina Vene, Mojca Božič Mijovski, et al.. (2019). Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation. European Journal of Clinical Pharmacology. 75(8). 1069–1075. 34 indexed citations
7.
Vanhove, Thomas, Hylke de Jonge, Henriëtte de Loor, et al.. (2018). Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers. Drug Metabolism and Disposition. 46(11). 1507–1513. 17 indexed citations
8.
9.
10.
11.
Malmström, Rickard E., Jovan P. Antović, Anton Pohanka, et al.. (2016). Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation. European Journal of Clinical Pharmacology. 72(6). 671–679. 28 indexed citations
12.
Andrés, Fernando de, Ephrem Engidawork, Anton Pohanka, et al.. (2015). The Psychostimulant Khat (Catha edulis) Inhibits CYP2D6 Enzyme Activity in Humans. Journal of Clinical Psychopharmacology. 35(6). 694–699. 22 indexed citations
13.
14.
Peredo, Inti, Anders Helldén, Anton Pohanka, et al.. (2015). Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study. BMJ Case Reports. 2015. bcr2014207694–bcr2014207694. 9 indexed citations
15.
Skeppholm, Mika, Paul Hjemdahl, Jovan P. Antović, et al.. (2014). On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation. Thrombosis Research. 134(4). 783–789. 42 indexed citations
16.
Dincq, Anne-Sophie, Paul Hjemdahl, Anton Pohanka, et al.. (2014). Estimation of dabigatran plasma concentrations in the perioperative setting. Thrombosis and Haemostasis. 113(4). 862–869. 49 indexed citations
17.
Antović, Jovan P., Mika Skeppholm, Liselotte Onelöv, et al.. (2013). Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma. European Journal of Clinical Pharmacology. 69(11). 1875–1881. 91 indexed citations
18.
Dubbelboer, Ilse R., Anton Pohanka, Rana Said, Staffan Rosenborg, & Olof Beck. (2012). Quantification of Tacrolimus and Three Demethylated Metabolites in Human Whole Blood Using LC–ESI–MS/MS. Therapeutic Drug Monitoring. 34(2). 134–142. 38 indexed citations
19.
Said, Rana, Anton Pohanka, Maria Andersson, Olof Beck, & Mohamed Abdel‐Rehim. (2011). Determination of remifentanil in human plasma by liquid chromatography–tandem mass spectrometry utilizing micro extraction in packed syringe (MEPS) as sample preparation. Journal of Chromatography B. 879(11-12). 815–818. 49 indexed citations
20.
Bergman, Peter, Katrin Pütsep, Anton Pohanka, et al.. (2011). Studies on the Antibacterial Effects of Statins - In Vitro and In Vivo. PLoS ONE. 6(8). e24394–e24394. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shitalben Patel Breakdown of academic impact, for papers by X.-J. Zhao Breakdown of academic impact, for papers by Mark A. Gill Breakdown of academic impact, for papers by Therese M Chapman Breakdown of academic impact, for papers by Heather A. Friedel Breakdown of academic impact, for papers by HJ Rogers Breakdown of academic impact, for papers by B. Diquet Breakdown of academic impact, for papers by Charles M. Bliss Breakdown of academic impact, for papers by Nancy K. Hopkins Breakdown of academic impact, for papers by Francesca Esposito
Rankless by CCL
2026